COVID-19 - August 6, 2021
Vaccine based on Abera’s technology shows good results
The vaccine platform developed by Abera Bioscience has been used in a collaboration between researchers at Johns Hopkins University School of Medicine and Vrije Universiteit to produce and test a novel SARS-CoV-2 vaccine candidate. The results from a study in a golden hamster infection model were published earlier this summer, showing that the vaccine candidate […]
COVID-19 - August 2, 2021
Pfizer-BioNTech’s second dose triggers powerful immune response
A new study has revealed that the second dose of the Pfizer-BioNTech COVID-19 vaccine triggers massive immune response against the virus. Researchers at the Stanford University School of Medicine, US, have investigated the effect of the second Pfizer-BioNTech COVID-19 vaccine dose in the human body. The study, published in Nature, was designed to find out […]
COVID-19 - July 28, 2021
New Danish test determines how long vaccination remains effective
A Danish research team has developed a new and more rapid test method that determines whether a person’s antibodies continue to protect them – also against new variants. The test shows that the antibodies formed against a specific part of the virus are far more protective than others. The new test could be an important […]
COVID-19 - July 28, 2021
SynAct Pharma announces positive additional trial data
SynAct Pharma has announced additional results from all treated patients in the Phase 2a clinical trial of AP1189 in Covid-19 infected patients with pulmonary insufficiency. The study was setup with part 1, where all patients were treated with AP1189, and a part 2, a randomized placebo-controlled study testing AP1189 vs placebo, giving a total of […]
COVID-19 - July 28, 2021
New data about one dose of AstraZeneca’s Vaxzevria
Real-world data from Canada showed 82% and 87% effectiveness after one dose against hospitalization or death caused by Beta/Gamma and Delta variants respectively. Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of Canada and the Canadian Institutes of Health Research, published as a pre-print, demonstrated one dose of Vaxzevria […]
COVID-19 - July 21, 2021
Two different types of COVID-19 vaccines provide good protection
A new study from Umeå University shows that a first dose of AstraZeneca’s COVID-19 vaccine and a second dose of an mRNA COVID-19 vaccine gives a good immune response against COVID-19. A combination of different types of vaccines also leads to a significantly higher level of antibodies compared to having two doses of the same […]
